Racemic-(2S,6R)-1,2,3,4,5,6-hexahydro-2,6-methanobenzo[b]azocine-11-carboxylic acid
95%
- Product Code: 87070
CAS:
1250884-55-9
| Molecular Weight: | 217.27 g./mol | Molecular Formula: | C₁₃H₁₅NO₂ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD14581501 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C, sealed, dry |
Product Description:
This compound is primarily utilized in the field of medicinal chemistry and pharmacology due to its structural similarity to certain opioid analgesics. It is often studied for its potential binding affinity to opioid receptors, which could lead to the development of new pain management therapies. Researchers explore its derivatives to optimize efficacy, reduce side effects, and improve selectivity for specific receptor subtypes. Additionally, it serves as a key intermediate in the synthesis of more complex molecules aimed at treating chronic pain or opioid addiction. Its unique bicyclic structure also makes it a subject of interest in organic synthesis and drug design for creating novel bioactive compounds.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | ฿25,857.00 |
+
-
|
| 0.250 | 10-20 days | ฿50,193.00 |
+
-
|
Racemic-(2S,6R)-1,2,3,4,5,6-hexahydro-2,6-methanobenzo[b]azocine-11-carboxylic acid
This compound is primarily utilized in the field of medicinal chemistry and pharmacology due to its structural similarity to certain opioid analgesics. It is often studied for its potential binding affinity to opioid receptors, which could lead to the development of new pain management therapies. Researchers explore its derivatives to optimize efficacy, reduce side effects, and improve selectivity for specific receptor subtypes. Additionally, it serves as a key intermediate in the synthesis of more complex molecules aimed at treating chronic pain or opioid addiction. Its unique bicyclic structure also makes it a subject of interest in organic synthesis and drug design for creating novel bioactive compounds.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :